Outcome Predictors in Prosthetic Joint Infections Validation of a risk stratification score for Prosthetic Joint Infections in 120 cases

被引:0
|
作者
Wimmer, Matthias D. [1 ]
Randau, Thomas M. [1 ]
Friedrich, Max J. [1 ]
Ploeger, Milena M. [1 ]
Schmolder, Jan [1 ]
Strauss, Andreas C. [1 ]
Pennekamp, Peter H. [1 ]
Vavken, Patrick [1 ,2 ,3 ,4 ]
Gravius, Sascha [1 ]
机构
[1] Univ Hosp Bonn, Dept Orthopaed & Trauma Surg, Sigmund Freud Str 15, D-53113 Bonn, Germany
[2] Alphaclin Zurich, Kraftstr 29, CH-8044 Zurich, Switzerland
[3] Harvard Med Sch, Childrens Hosp Boston, Div Orthopaed Surg, Boston, MA USA
[4] Harvard Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA USA
来源
ACTA ORTHOPAEDICA BELGICA | 2016年 / 82卷 / 01期
关键词
infection; revision; resistance; score; risk factors; RESISTANT STAPHYLOCOCCUS-AUREUS; TOTAL HIP-ARTHROPLASTY; KNEE ARTHROPLASTY; STRATEGIES; MANAGEMENT;
D O I
暂无
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Prosthetic joint infections are a major challenge in total joint arthroplasty, especially in times of accumulating drug resistancies. Even though predictive risk classifications are a widely accepted tool to define a suitable treatment protocol a classification is still missing considering the difficulty in treating the causative pathogen antibiotically. In this study, we present and evaluate a new predictive risk stratification for prosthetic joint infections in 120 cases, treated with a two-stage exchange. Treatment outcomes in 120 patients with proven prosthetic joint infections in hip and knee prostheses were regressed on time of infection, systemic risk factors, local risk factors and the difficulty in treating the causing pathogen. The main outcome variable was "definitely free of infection" after two years as published. Age, gender, and BMI were included as co-variables and analyzed in a logistic regression model. 66 male and 54 female patients, with a mean age at surgery of 68.3 years +/- 12.0 and a mean BMI of 26.05 +/- 6.21 were included in our survey and followed for 29.0 +/- 11.3 months. We found a significant association (p < 0.001) between our score and the outcome parameters evaluated. Age, gender and BMI did not show a significant association with the outcome. These results show that our score is an independent and reliable predictor for the cure rate in prosthetic joint infections in hip and knee prostheses treated within a two-stage exchange protocol. Our score illustrates, that there is a statistically significant, sizable decrease in cure rate with an increase in score. In patients with prosthetic joint infections the validation of a risk score may help to identify patients with local and systemic risk factors or with infectious organisms identified as "difficult to treat" prior to the treatment or the decision about the treatment concept. Thus, appropriate extra care should be considered and provided.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 50 条
  • [31] Non-Candida Fungal Prosthetic Joint Infections
    Koutserimpas, Christos
    Chamakioti, Ifigeneia
    Zervakis, Stylianos
    Raptis, Konstantinos
    Alpantaki, Kalliopi
    Kofteridis, Diamantis P.
    Vrioni, Georgia
    Samonis, George
    DIAGNOSTICS, 2021, 11 (08)
  • [32] A comprehensive review of the diagnosis and management of prosthetic joint infections in the absence of positive cultures
    Parikh, Monisha S.
    Antony, Suresh
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2016, 9 (05) : 545 - 556
  • [33] Prosthetic joint infections due to Mycobacterium tuberculosis: A report of 5 cases
    Carrega, Giuliana
    Bartolacci, Valentina
    Burastero, Giorgio
    Finocchio, Giorgetta Casalino
    Ronca, Agostina
    Riccio, Giovanni
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2013, 4 (02): : 178 - 181
  • [34] Microbiological diagnostics of prosthetic hip joint infections
    Strzelec-Nowak, Dagmara
    Bogut, Agnieszka
    Niedzwiadek, Justyna
    Koziol-Montewka, Maria
    Sikora, Agnieszka
    POSTEPY MIKROBIOLOGII, 2012, 51 (03): : 219 - 225
  • [35] The role of microbial biofilms in prosthetic joint infections
    Gbejuade, Herbert O.
    Lovering, Andrew M.
    Webb, Jason C.
    ACTA ORTHOPAEDICA, 2015, 86 (02) : 147 - 158
  • [36] Debridement for prosthetic joint infections FUTURE THERAPIES
    Tsang, S-T. J.
    Morgan-Jones, R.
    Simpson, A. H. R. W.
    BONE & JOINT RESEARCH, 2020, 9 (06): : 311 - 313
  • [37] Antibiotic Therapy for Prosthetic Joint Infections: An Overview
    Le Vavasseur, Benjamin
    Zeller, Valerie
    ANTIBIOTICS-BASEL, 2022, 11 (04):
  • [38] Aspergillus fumigatus prosthetic bone and joint infections
    de Faucal, S.
    Wirth, G.
    Dutronc, H.
    Gabriel, F.
    Accoceberry, I.
    Dupon, M.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (02): : 148 - 150
  • [39] Optimising detection and prevention of prosthetic joint infections
    Kandel, Christopher
    Daneman, Nick
    BMJ QUALITY & SAFETY, 2019, 28 (05) : 349 - 351
  • [40] Empirical antibiotic therapy in prosthetic joint infections
    Sousa, Ricardo
    Pereira, Alexandre
    Massada, Marta
    da Silva, Manuel Vieira
    Lemos, Rui
    Castro, Jose Costa E.
    ACTA ORTHOPAEDICA BELGICA, 2010, 76 (02): : 254 - 259